Product Information
EFFEXOR XR 37.5 MG CAPSULE is a brand product labeled by Viatris Specialty LLC, priced at $17.6986 per EA under NDC 58151012577. Its NADAC has been published 94 times since Sep 11, 2024.
The High Outlier badge above means this manufacturer's average price in the VENLAFAXINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
37.5 mg/1
Manufacturer
Viatris Specialty LLCNDC
58151012577
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020699On Market Since
7/17/2024
Pharmacological Classes
Price Statistics
The NADAC for EFFEXOR XR 37.5 MG CAPSULE has been published 94 times since Sep 11, 2024, and over the history we have for it it has risen 7.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.6986 per EA |
|---|---|
| All-time high | $17.7137 (May 13, 2026) |
| All-time low | $16.3867 (Dec 18, 2024) |
| 52-week high | $17.7137 |
| 52-week low | $16.8486 |
| Median price | $16.8627 |
| Average price | $17.0057 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 94 |
| Tracking since | Sep 11, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EFFEXOR XR 37.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for EFFEXOR XR 37.5 MG CAPSULE, manufactured by Viatris Specialty LLC, is $17.6986 per EA (NDC 58151012577), effective Jun 24, 2026.
How has the price of EFFEXOR XR 37.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for EFFEXOR XR 37.5 MG CAPSULE has risen 7.6%. It has been tracked across 94 weekly CMS publications since Sep 11, 2024.
What are the highest and lowest recorded NADAC prices for EFFEXOR XR 37.5 MG CAPSULE?
Since Sep 11, 2024, the NADAC for EFFEXOR XR 37.5 MG CAPSULE has ranged from a low of $16.3867 (Dec 18, 2024) to a high of $17.7137 (May 13, 2026), with a median of $16.8627 per EA.
Are there cheaper alternatives to EFFEXOR XR 37.5 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VENLAFAXINE HCL ER 37.5 MG CAP, is $0.0850 per EA — about 100% below EFFEXOR XR 37.5 MG CAPSULE.
Who manufactures EFFEXOR XR 37.5 MG CAPSULE?
EFFEXOR XR 37.5 MG CAPSULE (NDC 58151012577) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification